| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.83▲ | 3.83▲ | 3.83▲ | 3.92▼ | 3.44▲ |
| MA10 | 3.54▲ | 3.54▲ | 3.54▲ | 3.72▲ | 3.68▲ |
| MA20 | 3.44▲ | 3.44▲ | 3.44▲ | 3.43▲ | 3.40▲ |
| MA50 | 3.79▲ | 3.76▲ | 3.74▲ | 3.66▲ | 3.03▲ |
| MA100 | 3.49▲ | 3.49▲ | 3.51▲ | 3.41▲ | N/A |
| MA200 | 3.30▲ | 3.14▲ | 3.09▲ | 3.04▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.102▲ | 0.099▲ | 0.098▲ | 0.090▲ | -0.002▼ |
| RSI | 59.151▲ | 59.165▲ | 59.221▲ | 57.718▲ | 59.060▲ |
| STOCH | 95.513▲ | 95.513▲ | 95.513▲ | 87.717▲ | 39.200 |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -21.090▲ | -34.444 |
| CCI | 117.471▲ | 117.471▲ | 117.471▲ | 68.814 | 69.582 |
|
Thursday, April 24, 2025 02:12 PM
Eupraxia Pharmaceuticals Inc. has announced participation in several upcoming investor and scientific conferences to present their clinical research. At the Osteoarthritis Research Society ...
|
|
Thursday, April 24, 2025 02:00 PM
Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology designed to optimize ...
|
|
Sunday, April 06, 2025 05:01 PM
Ex parte reexamination (EPRx) comes with risks and rewards for both patent challengers and patent owners. Patent challengers enjoy a lower threshold for institution and avoid the estoppel risk of ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/25 | 3.9913 | 4.01 | 3.86 | 3.86 | 4,146 |
| 30/04/25 | 4.10 | 4.10 | 4.10 | 4.10 | 1,390 |
| 28/04/25 | 3.865 | 4.00 | 3.75 | 3.99 | 9,539 |
| 25/04/25 | 3.8515 | 4.00 | 3.80 | 3.81 | 24,777 |
| 24/04/25 | 3.915 | 4.00 | 3.8101 | 3.85 | 24,309 |
| 23/04/25 | 3.78 | 3.98 | 3.765 | 3.84 | 30,800 |
| 22/04/25 | 3.492 | 3.90 | 3.492 | 3.85 | 11,100 |
| 21/04/25 | 3.38 | 3.49 | 3.38 | 3.48 | 33,600 |
| 17/04/25 | 3.185 | 3.29 | 3.185 | 3.29 | 6,900 |
| 16/04/25 | 3.26 | 3.26 | 3.17 | 3.17 | 4,400 |
|
|
||||
|
|
||||
|
|